Literature DB >> 29196363

Lesson of the month 1: Obesity hypoventilation (Pickwickian) syndrome: a reversible cause of severe pulmonary hypertension.

Frazer Warricker1, Zafir Islam1, Benoy N Shah2.   

Abstract

Obesity hypoventilation syndrome (OHS) is a condition in which an individual with a body mass index >30 kg/m2 develops daytime alveolar hypoventilation (defined as a resting PaCO2 >45 mmHg) that cannot be attributed to other pathologies. It is a condition with increasing prevalence and rising cost to healthcare systems worldwide. Right heart failure and pulmonary hypertension are well-known complications of this syndrome. Here, we present the case of a female patient with OHS who presented to our centre with severe pulmonary hypertension, which resolved with appropriate treatment. We also review this clinical condition and its diagnosis and management. © Royal College of Physicians 2017. All rights reserved.

Entities:  

Keywords:  Pickwickian ­syndrome; obesity hypoventilation syndrome; obstructive sleep apnoea; pulmonary hypertension

Mesh:

Year:  2017        PMID: 29196363      PMCID: PMC6297698          DOI: 10.7861/clinmedicine.17-6-578

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  6 in total

Review 1.  The obesity hypoventilation syndrome.

Authors:  Amy L Olson; Clifford Zwillich
Journal:  Am J Med       Date:  2005-09       Impact factor: 4.965

2.  Pulmonary hypertension in hypoventilation syndromes.

Authors:  Robert Naeije
Journal:  Eur Respir J       Date:  2014-01       Impact factor: 16.671

3.  Defining obesity hypoventilation syndrome.

Authors:  Aiman Tulaimat; Stephen Littleton
Journal:  Thorax       Date:  2014-01-03       Impact factor: 9.139

4.  Obesity hypoventilation syndrome: does the current definition need revisiting?

Authors:  Nicholas Hart; Swapna Mandal; Ari Manuel; Babak Mokhlesi; Jean-Louis Pépin; Amanda Piper; John R Stradling
Journal:  Thorax       Date:  2013-08-28       Impact factor: 9.139

5.  Pulmonary hypertension in obesity-hypoventilation syndrome.

Authors:  Christoph A Kauppert; Iris Dvorak; Florian Kollert; Frank Heinemann; Rudolf A Jörres; Michael Pfeifer; Stephan Budweiser
Journal:  Respir Med       Date:  2013-09-28       Impact factor: 3.415

6.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

  6 in total
  2 in total

Review 1.  Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications.

Authors:  Jun Ren; Ne N Wu; Shuyi Wang; James R Sowers; Yingmei Zhang
Journal:  Physiol Rev       Date:  2021-05-05       Impact factor: 37.312

2.  ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs.

Authors:  Carol Reinero; Lance C Visser; Heidi B Kellihan; Isabelle Masseau; Elizabeth Rozanski; Cécile Clercx; Kurt Williams; Jonathan Abbott; Michele Borgarelli; Brian A Scansen
Journal:  J Vet Intern Med       Date:  2020-02-17       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.